Han Ngo is a pharmacist who is specialized in Oncology in Fullerton, California. Patients can reach her at 2151 N Harbor Blvd Ste 2200, Fullerton or contact her on 714-446-7149. Active license number of Han Ngo is 61620 for Oncology in California. Han Ngo is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
Han Ngo speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Han Ngo
Specialization:
Oncology
Credentials:
PHARM. D
Gender:
Female
Location:
2151 N Harbor Blvd Ste 2200, Fullerton, California, 92835-3825
Phone:
714-446-7149
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Han Ngo are as mentioned below.
NPI Number:
1477908929
NPI Enumeration Date:
03 May, 2016
NPI Last Update On:
03 May, 2016
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Han Ngo are as mentioned below.
Specialization
License Number
State
Status
Oncology
61620
California
Primary
Pharmacist
61620
California
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
2151 N Harbor Blvd Ste 2200, Fullerton, California
Zip:
92835-3825
Phone Number:
714-446-7149
Fax Number:
--
Patients can reach Han Ngo at 2151 N Harbor Blvd Ste 2200, Fullerton, California or can call on phone at 714-446-7149.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.